Gene Expression of the Hematopoietic Cell Phosphatase in Juvenile Myelomonocytic Leukemia

References

• Niemeyer C. M., Aricò M., Basso G., Biondi A., Cantù-Rajnoldi A., Creutzig U., Haas O., Harbott J., Hasle H., Kerndrup G., Locatelli F., Mann G., Stollmann-Gibbels B., van t Verr-Korthof E. T., van Wering E., Zimmermann M. Chronic myelomonocytic leukemia in childhood: a report of 110 cases. Blood 1997; 89: 3534–3543
   PubMed Web of Science ®Google Scholar
• Aricò M., Biondi A., Pui C-H. Juvenile myelomonocytic leukemia. Blood, 90: 479–488
   Google Scholar
• Emanuel P. D., Bates L. J., Castleberry R. P., Gualtieri R. J., Zuckerman K. S. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 1991; 77: 925–929
   PubMed Web of Science ®Google Scholar
• Freeburn R. W., Gale R. E., Wagner H. M., Linch D. C. Analysis of the coding sequence for the GM-CSF receptor alpha and beta chains in patients with juvenile chronic myeloid leukemia (JCML). Experimental Hematology 1997; 25: 306–311
   PubMed Web of Science ®Google Scholar
• Frankel E., Lilly M., Kreitman R., Hogge D., Beran M., Freedman M. H., Emanuel P. D., McLain C., Hall P., Tagge E., Berger M., Eaves C. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia. Blood 1998; 92: 4279–4286
   PubMed Web of Science ®Google Scholar
• Kalra R., Paderanga D. C., Olson K., Shannon K. M. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras. Blood 1994; 84: 3435–3439
   PubMed Web of Science ®Google Scholar
• Flotho C., Schmahl G., Rath A., Gerhardt T., Niemeyer C. Ras mutations in children with chronic myelomonocytic leukemia. Medical and Pediatric Oncology 1996; 27: 300
   Google Scholar
• Bartram C. R. Molecular genetic aspects of myelodysplastic syndromes. Hematology — Oncology Clinics of North America 1992; 6: 557–570
   PubMed Web of Science ®Google Scholar
• Miyauchi J., Asada M., Sasaki M., Tsunematsu Y., Kojima S., Mizutani S. Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood 1994; 83: 2248–2254
   PubMed Web of Science ®Google Scholar
• Side L. E., Emanuel P., Taylor B., Franklin J., Thompson P., Castleberry R., Shannon K. M. Mutations of the NF1 gene in leukemias from children without evidence of neurofibromatosis type I. Blood 1997; 90: 414a
   PubMedGoogle Scholar
• Basu T. N., Gutmann D. H., Fletcher J. A., Glover T. W., Collins F. S., Downward J. Aberrant regulation of ras proteins in malignant tumor cells from type 1 neurofibromatosis patients. Nature 1992; 356: 713–715
   PubMed Web of Science ®Google Scholar
• Emanuel P. D., Shannon K. M., Castleberry R. P. Juvenile myelomonocytic leukemia: molecularunderstanding and prospects for therapy. Molecular Medicine Today 1996; 468–475
   PubMedGoogle Scholar
• Bollag G., Clapp D. W., Shih S., Adler F., Zhang Y. Y., Thompson P., Lange B. J., Freedman M. H., McCormick F., Jacks T., Shannon K. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nature Genetics 1996; 12: 144–148
   PubMed Web of Science ®Google Scholar
• Quelle F. W., Sato N., Witthuhn B. A., Inhorn R. C., Eder M., Miyajima A., Griffin J. D., Ihle J. N. Jak2 associates with the βc chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Molecular and cellular biology 1994; 14: 4335–4341
   PubMed Web of Science ®Google Scholar
• Ihle J. N., Witthuhn B. A., Quelle F. W., Yamamoto K., Silvennoinen O. Signaling through the hematopoietic cytokine receptors. Annual review of immunology 1995; 13: 369–398
   PubMed Web of Science ®Google Scholar
• Yi T., Mui A L-F., Krystal G., Ihle J. N. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor β chain and down-regulates IL-3 induced tyrosine phosphorylation and mitogenesis. Molecular & Cellular Biology 1993; 13: 7577–7586
   Web of Science ®Google Scholar
• Kon-Kozlowski M., Pani G., Pawson T., Siminovitch K. A. The tyrosine phosphatase PTPIC associates with Vav. Grb2 and mSosl in hematopoietic cells. Journal of Biological Chemistry 1996; 271: 3856–3862
   PubMed Web of Science ®Google Scholar
• Shultz L. D., Schweitzer P. A., Rajan T. V., Yi T., Ihle J. N., Matthews R. J., Thomas M. L., Beier D. R. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 1993; 73: 1445–1454
   PubMed Web of Science ®Google Scholar
• Jiao H., Yang W., Berrada K., Tabrizi M., Shulz L., Yi T. Macrophages from motheaten and viable motheaten mice show increased proliferative responses to GM-CSF: detection of potential HCP substrates in GM-CSF signel transduction. Experimental hematology 1997; 25: 592–600
   PubMed Web of Science ®Google Scholar
• Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain terminating inhibitors. Proceedings of the National Academy of Sciences of the United States of America 1977; 74: 5463–5467
   PubMed Web of Science ®Google Scholar
• Pregel M. J., Shen S.-H., Storer A. C. Regulation of protein tyrosine phosphatase 1 C: opposing effects of the two src homology 2 domains. Protein engineering 1995; 8: 1309–1316
   PubMedGoogle Scholar
• Pei D., Wang J., Walsh C. T. Differentia] functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1. Proceedings of the National Academy of Sciences of the United States of America 1996; 93: 1141–1145
   PubMed Web of Science ®Google Scholar
• Andersson P., LeBlanc K., Eriksson B-A., Samuelsson J. No evidence for an altered mRNA expression or protein level of haematopoietic cell phosphatase in CD34+ bone marrow progenitor cells or mature peripheral blood cells in polycythemia vera. European Journal of Haematology 1997; 59: 310–317
   PubMed Web of Science ®Google Scholar
• Banville D., Stocco R., Shen S. H. Human protein tyrosine phosphatase 1C (PTPN6) gene structure: alternate promoter usage and exon skipping generate multiple transcripts. Genomics 1995; 27: 165–173
   PubMed Web of Science ®Google Scholar
• Pei D., Lorenz U., Klingmüller U., Neel B. G., Walsh C. T. Intramolecular regulation of protein tyrosine phospnatase SH-PTP1: a new function for src homology 2 domains. Biochemistry 1994; 33: 15483–15493
   PubMed Web of Science ®Google Scholar
• Tsui H. W., Siminovitch K. A., de Souza L., Tsui F. W. L. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nature Genetics 1993; 4: 124–129
   PubMed Web of Science ®Google Scholar
• Kozlowski M., Mlinaric-Rascan I., Feng G.-S., Shen R., Pawson T., Siminovitch K. A. Expression and catalytic activity of the tyrosine phosphatase PTPIC is severely impaired in motheaten and viable motheaten mice. Journal of Biological Chemistry 1993; 178: 2157–2163
   Google Scholar